CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Hackensack Meridian Health

Patrick Young, President of Population Health

Using Technology to Advance Population Health Strategies

Patrick Young

Patrick Young

As hospitals and health systems continue to grapple with COVID-19, population health should be part of every organization’s strategy. Having been on the provider and payer side of healthcare for more than 20 years, I’m bullish on the move to whole person care. Today’s technology has made it easier to gather a variety of data about a patient, giving a more wholesome view of who they are and the hurdles they face. At Hackensack Meridian Health(HMH)our population health strategy is focused on providing patients the right care, at the right time, and in the right place. If we execute that approach successfully, we ultimately improve our patient’s quality of care while lowering medical costs.


Reenvisioning the referral


For years, referrals have beena way to provide a patient the next level of clinical care. What if we looked at referrals through a broader lens and saw referrals as a way to address a patient’s other needs like housing or food insecurity. These social determinants of health affect a person’s overall wellbeing and could prevent them from achieving their optimal health. This is why HMH began a community health program to tackle social determinants of health and drive whole-person care.


Part of our social determinants of health program includes creating new kind of referral platform. A platform that connects patients with resources in the community that can help them find a path to better health. Tomorrow’s patient may leave with a referral for a cardiologist along with a referral to the local food bank or a free mental health counselor. Our ability to connect patients with these valuable resources helps us address the whole patient and become a true health champion.


Using technology to enable your population health strategy


Data is only useful if you make it credible and actionable. Like many other hospitals and systems, we have numerous data feeds and tools across our system, and we must ensure that the information can drive better care. Our work with Cerner and Lumeris, through their Maestro™ collaboration, is helping us do just that. We integrate EHR (including data from Epic and others), claims, lab, pharmacy and other relevant data from soon to be more than 100 clinical data sources, into our central data warehouse in Cerner’s HealtheIntent℠ for aggregation and normalization. Then we push predictive analytics and actionable insights from Lumeris into our Epic EHR platform where it’s easily accessed by our care team. The care team leverages this data, with the support of Lumeris, to identify patients with rising risk and open care gaps in need of the right interventions.


Clinical transparency


Once you have actionable data, you need to share these insights with your clinicians. Empowering your providers is essential so they can deliver the highest quality care while managing medical costs. Our clinically integrated network, Hackensack Meridian Health Partners, is our organized physician network with approximately 4,600 participating physicians serving more than 371,000 at-risk lives. In partnership with Lumeriswe created physician scorecards to communicate performance transparently and encourage best practice sharing.


With this holistic approach to value-based care—a progressive risk contracting strategy, focused clinical transformation, patient engaged shared decision making, and the right technology infrastructure and operating model—we can capture the full picture of our patients and take action across the entire population.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/cxoinsight/using-technology-to-advance-population-health-strategies-nwid-2926.html